Progyny celebrates ten years of transforming family building benefits, supporting millions through innovative women's health solutions.
Quiver AI Summary
Progyny, a leader in women’s health and family building solutions, announces its decade-long impact on improving access to essential benefits for millions. Throughout 2026, the company will celebrate this milestone by honoring the contributions of its members, partners, and employers who have supported its mission since its founding in 2016. Progyny has seen significant growth, expanding its services to over 600 employers and supporting over 470,000 members globally. The company has recorded impressive outcomes in fertility treatments, with higher pregnancy rates and reduced costs for members. Key events include partnerships with RESOLVE for National Infertility Awareness Week and initiatives like “Yeah, Baby Day.” Progyny aims to continue innovating in women's health and family-building benefits, striving for better care standards and patient outcomes.
Potential Positives
- Progyny celebrates its 10-year anniversary, highlighting significant growth from 5 founding employers to over 600, now covering 7.2 million lives globally.
- The company boasts a nearly 100% client retention rate over the past decade, indicating strong satisfaction among employers and members.
- Progyny leads in clinical outcomes, reporting 12% higher pregnancy rates per IVF transfer and 41% fewer egg retrievals per live birth compared to national averages.
- Initiatives such as partnering with RESOLVE during National Infertility Awareness Week promote awareness and position Progyny as a leader in the conversation around infertility and family building solutions.
Potential Negatives
- The press release focuses predominantly on past achievements and future initiatives, which may suggest a lack of immediate, impactful new developments or products being launched, potentially indicating stagnation in innovation.
- The emphasis on celebrating a decade of achievements might detract from addressing current challenges or criticisms the company may be facing, potentially raising concerns about transparency in their ongoing operations.
- While Progyny highlights impressive client retention rates and positive outcomes, the absence of detailed statistics or comparisons to competitors could lead stakeholders to question the broader market positioning and effectiveness of their solutions.
FAQ
What is Progyny's role in women's health?
Progyny is a global leader in women’s health and family building solutions, providing comprehensive benefits to support individuals and families.
How long has Progyny been supporting families?
Progyny has been supporting families for ten years, since its founding in 2016.
What initiatives is Progyny celebrating for its 10-year anniversary?
Progyny is celebrating with initiatives such as community events, lighting the Empire State Building, and participating in the NASDAQ Closing Bell Ceremony.
What impact has Progyny had on fertility success rates?
Progyny delivers significantly higher pregnancy rates and lower egg retrievals per live birth compared to national averages, improving member experiences during treatment.
Where can I find more information about Progyny?
More information about Progyny and its anniversary activities is available on their official website, www.progyny.com.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$PGNY Insider Trading Activity
$PGNY insiders have traded $PGNY stock on the open market 10 times in the past 6 months. Of those trades, 1 have been purchases and 9 have been sales.
Here’s a breakdown of recent trading of $PGNY stock by insiders over the last 6 months:
- PETER ANEVSKI (CHIEF EXECUTIVE OFFICER) purchased 79,500 shares for an estimated $1,930,896
- MARK S. LIVINGSTON (CHIEF FINANCIAL OFFICER) has made 0 purchases and 3 sales selling 21,975 shares for an estimated $560,362.
- ALLISON SWARTZ (EVP, GC) has made 0 purchases and 6 sales selling 10,383 shares for an estimated $206,979.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$PGNY Revenue
$PGNY had revenues of $318.4M in Q4 2025. This is an increase of 6.69% from the same period in the prior year.
You can track PGNY financials on Quiver Quantitative's PGNY stock page.
$PGNY Hedge Fund Activity
We have seen 142 institutional investors add shares of $PGNY stock to their portfolio, and 169 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- BLACKROCK, INC. removed 1,858,195 shares (-12.5%) from their portfolio in Q4 2025, for an estimated $47,718,447
- WELLINGTON MANAGEMENT GROUP LLP added 1,621,688 shares (+260.9%) to their portfolio in Q4 2025, for an estimated $41,644,947
- CITADEL ADVISORS LLC added 1,238,899 shares (+134.4%) to their portfolio in Q4 2025, for an estimated $31,814,926
- MARSHALL WACE, LLP removed 1,072,733 shares (-92.5%) from their portfolio in Q4 2025, for an estimated $27,547,783
- ALLIANZ ASSET MANAGEMENT GMBH added 841,365 shares (+4141.8%) to their portfolio in Q4 2025, for an estimated $21,606,253
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 836,652 shares (+inf%) to their portfolio in Q4 2025, for an estimated $21,485,223
- LOOMIS SAYLES & CO L P added 775,580 shares (+inf%) to their portfolio in Q4 2025, for an estimated $19,916,894
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$PGNY Analyst Ratings
Wall Street analysts have issued reports on $PGNY in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Citizens issued a "Market Outperform" rating on 01/20/2026
To track analyst ratings and price targets for $PGNY, check out Quiver Quantitative's $PGNY forecast page.
$PGNY Price Targets
Multiple analysts have issued price targets for $PGNY recently. We have seen 7 analysts offer price targets for $PGNY in the last 6 months, with a median target of $28.0.
Here are some recent targets:
- Glen Santangelo from Barclays set a target price of $23.0 on 03/20/2026
- Richard Close from Canaccord Genuity set a target price of $19.0 on 03/11/2026
- David Larsen from BTIG set a target price of $30.0 on 03/05/2026
- Jailendra Singh from Truist Securities set a target price of $28.0 on 03/02/2026
- Scott Schoenhaus from Keybanc set a target price of $28.0 on 03/02/2026
- Constantine Davides from Citizens set a target price of $30.0 on 01/20/2026
- Lisa Gill from JP Morgan set a target price of $26.0 on 11/11/2025
Full Release
NEW YORK, April 01, 2026 (GLOBE NEWSWIRE) -- Over the past ten years, millions of individuals and families have gained access to life-changing benefits through Progyny , a global leader in women’s health and family building solutions. Progyny today announces that throughout the year, it will honor the collective efforts of its members, employers, providers, and industry partners who have helped shape this decade of progress. The company has redefined what’s possible in the benefits industry by combining clinical expertise, innovation, and a personalized approach to support members at every stage, from preconception through menopause.
“Ten years ago, we set out to transform family building benefit coverage at a time when support was limited and often out of reach,” said Pete Anevski, CEO, Progyny. “Today, we’re helping millions of people access the care and support they need across every stage of their health journey, from building the family of their dreams to navigating life’s biggest transitions; from preconception to pregnancy, parenting, and menopause. This ten-year milestone reflects what’s possible when employers, providers, and advocates come together to solve one of the biggest challenges in healthcare.”
The company will mark the occasion with a series of initiatives throughout the year centered on community and sparking national conversation. One of the cornerstone events will be during National Infertility Awareness Week (April 19–25), when Progyny will partner with RESOLVE: The National Infertility and Family Building Association to light the Empire State Building in orange alongside infertility advocate and celebrity Whitney Port on April 20. Progyny, RESOLVE, leading employers, and industry advocates will also participate in the NASDAQ Closing Bell Ceremony on April 21, raising awareness for the millions of individuals navigating infertility and family building journeys.
Progyny kicked off the anniversary with “ Yeah, Baby Day, ” an annual event launched on March 25, 2026, to celebrate each person's milestones, highlighting the moments where support can make all the difference.
A Decade of Partnership, Impact, and Innovation
Since entering the market in 2016, Progyny has supported over 470,000 members and expanded from 5 founding employers to more than 600 employers, covering 7.2 million lives. The company has also grown its global benefits solution to serve employees in over 100 countries, while broadening care across preconception, pregnancy, leave and benefits navigation, postpartum care, parenting, and menopause services. This level of exceptional care delivery has led to significant cost savings for employers and members, and a nearly 100% client retention rate over the past ten years.
“It’s one of our most valued benefits because of the meaningful impact it’s had on so many of our employees’ lives,” said Lisa Wywoda, Head of Total Rewards at Unilever. “Over the past ten years, we’ve been able to support employees across the full journey — from early family planning and egg freezing through IVF — in a way that feels seamless and centered around our needs.”
This level of expertise and clinical integration has also enabled Progyny to build one of the largest fertility data sets, showing that the company delivers 12% higher pregnancy rates per IVF transfer, 41% fewer egg retrievals per live birth, 23% higher live birth rates, and more than four times faster access to menopause care compared to the national average. These superior outcomes lead to a significantly better experience for members and their families during difficult times.
“When we found out we had fertility coverage through Progyny, it felt like a whole new door opened for us,” said Erin Antoniak, Progyny member. “Fertility treatment can be incredibly expensive, and having that support allowed us to move forward with the care we needed during a really uncertain time.”
Over the years, Progyny has helped lead the transformation of women’s health and family building benefits by being the first to introduce a fully inclusive definition of infertility, now recognized by ASRM, and first to offer a fully managed benefits solution with integrated clinical oversight, pharmacy support, and rigorous provider inclusion and credentialing standards. With 10 years of groundbreaking work behind it, Progyny is only just getting started. The company plans to continue to invest in new technologies, work with leading providers to advance clinical innovation, and shape national conversations to raise the standard of care across women’s health.
For more information on Progyny’s 10-year anniversary activities, visit 10 years of Progyny .
About Progyny
Progyny (Nasdaq: PGNY) is a global leader in women’s health and family building solutions, trusted by the nation’s leading employers, health plans and benefit purchasers. We envision a world where everyone can realize their dreams of family and ideal health. Our outcomes prove that comprehensive, inclusive, and intentionally designed solutions simultaneously benefit employers, patients and physicians.
Our benefits solution empowers patients with concierge support, coaching, education, and digital tools; provides access to a premier network of fertility and women's health specialists who use the latest science and technologies; drives optimal clinical outcomes; and reduces healthcare costs.
Headquartered in New York City, Progyny has been recognized for its leadership and growth as a TIME100 Most Influential Company, CNBC Disruptor 50, Modern Healthcare's Best Places to Work in Healthcare, Forbes' Best Employers, Financial Times Fastest Growing Companies, Inc. 5000, Inc. Power Partners, and Crain's Fast 50 for NYC. For more information, visit www.progyny.com .
For Further Information, Please Contact:
Media:
Alexis Ford
[email protected]
Investors:
James Hart
[email protected]